Compared to other major orthopedic markets, the Asia Pacific trauma device market will be somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma cases. Although trauma device market will be limited by pricing pressures and a challenging reimbursement environment and nationalist policies in China and India, once the market stabilizes, advancements in medical facilities and MNCs increasingly focusing on physician training will lead to overall trauma device market expansion through 2029.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in the Asia Pacific region across a 10-year period.

The COVID-19 pandemic will affect the trauma device market.

To what extent will COVID-19 impact the trauma device market in Asia Pacific countries?

How quickly are procedure volumes expected to recover?

Health care reforms in countries like India and China will support growing procedure volumes in the Asia Pacific region.

How will reforms like Ayushman Bharat Yojana impact the Indian trauma market? How will it affect choices between MNC and domestic manufacturer products?

How will government initiatives, such as China's two-invoice policy, affect the growth potential of this market?

What strategies will the companies use to increase their market share in the presence of these health care reforms and protectionist trade policies in the Asia Pacific trauma device market?

The aging population and rising middle class in China and India will largely dictate the growth of the overall market.

As the largest market in the Asia Pacific region, to what extent will procedure volumes grow within the Chinese market for trauma devices?

How will the Indian market grow in comparison to China and the rest of the Asia Pacific region?

What are physicians' opinions about various segments in trauma device market?

In the Asia Pacific trauma device market, there is strong competition between MNCs and domestic players, leading to price declines.

Which local competitors have been able to capture notable shares within the Asia Pacific trauma device space?

What are the key competitive strategies used by the domestic competitors to remain competitive in the trauma market?

What other strategies are MNCs using to remain competitive in the face of strong pricing pressures?

How will purchasing priorities in this region evolve going forward?

The IM nail market will be the fastest-growing segment of the Asia Pacific trauma device market through 2029.

What factors will drive this growth?

What product innovations are competitors pursuing to capitalize on the growing IM nail market segment?

Table of contents

  • Trauma Devices - Market Insights - Asia Pacific

Author(s): Diwakar Bahuguna, MBA

Diwakar Bahuguna is a senior analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Decision Resources Group, specializing in hyaluronic acid viscosupplementation and Latin American aesthetic injectables markets. Diwakar holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali.

Follow Diwakar on twitter: @diwakar_zero7